GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,054,000 | +251.9% | 94,975 | +230.1% | 0.20% | +212.3% |
| Q2 2019 | $1,152,000 | -49.6% | 28,775 | -47.4% | 0.06% | -52.6% |
| Q1 2019 | $2,285,000 | -22.1% | 54,675 | -25.1% | 0.14% | +3.0% |
| Q3 2018 | $2,932,000 | -9.8% | 73,000 | -8.9% | 0.13% | -19.9% |
| Q3 2017 | $3,252,000 | +513.6% | 80,100 | +551.2% | 0.17% | +492.9% |
| Q2 2017 | $530,000 | -88.4% | 12,300 | -88.7% | 0.03% | -86.7% |
| Q1 2017 | $4,574,000 | +20.4% | 108,500 | +31.8% | 0.21% | +61.1% |
| Q1 2015 | $3,799,000 | -61.0% | 82,335 | -63.9% | 0.13% | -64.0% |
| Q4 2014 | $9,742,000 | +2360.1% | 227,955 | +2544.8% | 0.36% | +1922.2% |
| Q3 2014 | $396,000 | -86.8% | 8,619 | -84.6% | 0.02% | -88.5% |
| Q2 2014 | $2,991,000 | +103.9% | 55,930 | +103.6% | 0.16% | +100.0% |
| Q1 2014 | $1,467,000 | -61.7% | 27,464 | -61.7% | 0.08% | -61.6% |
| Q4 2013 | $3,827,000 | +38.4% | 71,692 | +30.1% | 0.20% | +34.4% |
| Q3 2013 | $2,765,000 | – | 55,120 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |